Persistent URL of this record https://hdl.handle.net/1887/106212
In Collections
This item can be found in the following collections:
Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study
- All authors
- Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.C.; Kremer, J.M.; Zerbini, C.A.F.; Cardiel, M.; Cohen, S.B.; Nash, P.T.; Song, Y.W.; Tegzova, D.; Wyman, B.; Gruben, D.; Benda, B.; Wallenstein, G.; Zwillich, S.H.; Bradley, J.D.; Connell, C.A.; ORAL Scan Investigators
- Date
- 2011-10-31
- Journal
- Arthritis and Rheumatism
- Volume
- 63
- Issue
- 10
- Pages
- S1017 - S1018